B6 against brain injury has been reported (18, 19) , together with cell culture studies indicating the neuroprotective effect of B6 (20) . A recent epidemiological study has also indicated that low intake of B6 is associated with an increased risk of Parkinson's disease (21) . In addition, there is evidence for an association between B6 deficiency and renal failure by the production of calcium oxalate renal calculi (22) . Deficiency of B6 is associated with the elevation of blood homocysteine, a risk factor for cardiovascular disease, by impairing homocysteine metabolism (23, 24) . A study by Huq et al. has demonstrated the modulation of nuclear corepressor receptor interacting protein 140 (RIP140) by pyridoxal 5′-phosphate (PLP) in adipocytes (25) . More recently, we have reported the modulation of proliferator-activated receptor-g (PPARg)-dependent gene expression in adipose tissue by dietary supplemental B6 (26) .
Recent evidence suggests that inadequate daily intake of B6 is prevalent in the US and Japan (27, 28) . This information, together with the anti-disease effects of B6 in certain tissues as mentioned above, raises the question of which tissues have higher susceptibility to B6 added to the diet. At present, there is limited information on comparison of the responses of the levels of B6-vitamers among several tissues to dietary level of B6 in a single experiment (29) . In this study, we examined the influence of dietary level of PN on the levels of 
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Comparative Study on the Responses of Concentrations of B 6 -Vitamers in Several Tissues of Mice to the Dietary Level of Pyridoxine
Materials and Methods
Animals and diets. Male CD-1 (ICR):Crj mice (4 wk of age; Hiroshima Experimental Animal Center, Japan) were housed in groups of two or three in metal cages in a room with controlled temperature (2461˚C) and a 12-h light : dark cycle (lights on, 0800-2000 h). They had free access to food and deionized water. The mice were maintained according to the Guide for the Care and Use of Laboratory Animals established by Hiroshima University Animal Research Committee. After consuming a nonpurified commercial solid diet (MF, Oriental Yeast Co., Ltd., Tokyo, Japan) for 1 wk, the mice (mean weight, 26 g) were divided into four groups of 28. The basal diet consisted of the following components (g/kg diet): gelatinized cornstarch, 302; casein, 200; sucrose, 200; corn oil, 200; cellulose, 50; AIN-93 G mineral mixture, 35; AIN-93 vitamin mixture (PN-free), 10; and l-cystine, 3. PN HCl (Nacalai Tesque, Inc., Kyoto, Japan) was added to the basal diet at the levels of 0, 1, 7 and 35 mg/kg diet. The level of PN HCl/kg diet recommended in the AIN-93 diet is 7 mg (16), and 1 mg PN HCl/kg diet has been reported to be the minimum level required for preventing growth depression caused by B6 deficiency (17) . The experimental feeding period was 5 wk. Since feeding on a B6-free diet for more than 7 wk caused growth depression, a feeding period of 5 wk was selected. Food intake and body weight were measured daily. At the end of the experimental period, the diets were removed from the cages at 0800 h, and the animals were killed at 1300-1500 h by decapitation under anesthesia with diethyl ether. Blood was collected and serum was separated by centrifugation at 2,000 3g for 20 min and stored at 270˚C. Several tissues, including stomach, small intestine (10-cm segment of duodenum and jejunum just distal to the pylorus), colon, liver, lung, kidney, spleen, heart, gastrocnemius muscle, epididymal adipose tissue (adipose tissue) and whole brain, were immediately obtained, rinsed with saline, and stored at 270˚C until analysis of B6 metabolites.
Concentrations of serum and tissue B6-vitamers. The analysis of PLP, PN, PL and PM was conducted by an HPLC system equipped with a 4.6 mm (ID)3250 mm (L) column packed with 10 mm pore size TSK-gel ODS-120A (Tosoh) (30) . PLP was converted to pyridoxic acid 5′-phosphate and measured. B6-vitamers from serum and tissues were extracted using 1 mol/L perchloric acid. The pH of the extracted sample was adjusted to pH 3.5 with 5 m KOH, centrifuged at 12,000 3g at 4˚C for 10 min prior to analysis of PM, PL, and PN. The PLP samples were adjusted to pH 7.5 with the KOH solution, centrifuged at 12,000 3g at 4˚C for 10 min and supernatant was collected and 0.1 m KCN was added for extraction of PLP and agitated at 50˚C for 3 h. Thereafter, the pH was readjusted to 3.5 with 1 m HCl. Then the samples were let to stand at 25˚C for 24 h. The resulting solutions of PLP and other B6 metabolites were mixed with deionized water. Prior to injection into an HPLC line, all of the solutions were passed through a 0.45 mm pore size membrane filter, and analyzed by an HPLC device with a fluorometric detector. For the determination of PN, PL and PM, the fluorescence spectrophotometer was set at an emission wavelength of 390 nm with an excitation wavelength of 305 nm. For the determination of PLP, a fluorescence measurement was set at an emission wavelength of 420 nm with an excitation wavelength of 320 nm.
Statistical analysis. Data are expressed as means6SE. Statistical analysis was performed with one-way ANOVA and Scheffe's multiple-range test. Data analysis was performed using Excel Toukei 2010 for Windows (Social Survey Research Information Co., Ltd., Tokyo, Japan). Statistical significance of the difference among means was estimated at p,0.05. Some data underwent regression analysis and the correlation coefficient was calculated. 
Results
Food intake did not differ among the four groups of mice (data not shown). There was a small but significant difference in the final body weight between 0 mg and 7 mg PN HCl/kg diets (p,0.05) ( Table 1) . Dietary supplemental PN HCL caused a significant elevation in spleen weight in a dose-dependent manner (one-way ANOVA, p,0.01). The weight of heart with the 0 mg PN HCl/kg diet was slightly lower than those of other groups (p,0.05). The weights of other tissues were unaffected.
Although there was no difference in serum PLP between the 0 mg PN HCl/kg and 1 mg PN HCl/kg diet groups, the PLP level in the 7 mg PN HCl/kg diet group was markedly higher than that in the 1 mg PN HCl/kg diet group (p,0.05) ( Table 2 ). The serum PLP in the 7 mg PN HCl/kg and 35 mg PN HCl/kg diet groups did not differ.
The levels of PLP in heart and muscle did not differ among the 0, 38 and 1 .08, respectively. The relationship between these ratios and the tissue PLP levels at the 7 mg PN HCl/kg diet is shown in Fig. 1 . In general, there appeared to be a higher response of PLP to dietary supplemental PN HCl in the tissues containing a lower concentration of PLP with the 7 mg PN HCl/kg diet (Fig. 1) .
Compared with the 0 mg PN HCl/kg diet, the 1 mg PN HCl/kg diet significantly elevated the PLP level in small intestine, liver and kidney (p,0.05), but not in other tissues ( Table 2 ). In general, the responses of the PLP level in many tissues differed remarkably between 1 mg and 7 mg PN HCl/kg diet. Compared with the 7 mg PN HCl/kg diet, the 35 mg PN HCl/kg diet further elevated the PLP level in adipose tissue, spleen and stomach (p,0.05), but not in other tissues. Dietary supplementation of B6 appeared to cause a dose-dependent elevation in colon PLP across a wide range of dietary PN HCl levels (from 0 mg to 35 mg PN HCl/kg diets).
Dietary supplemental PN HCl significantly elevated the PN and PM levels in the small intestine in a dosedependent manner (ANOVA analysis, p,0.05) without affecting the levels of PL ( Table 2) . The colon PN level was also elevated by dietary supplemental PN, but the PL and PM levels were unaffected. In other tissues, the levels of PN, PL and PM were unaffected by dietary supplemental PN, except for in the brain and lung. The lung PL level was higher in the PN-supplemented groups (p,0.05). The brain PL was not detected in the 0 and 1 mg PN HCl/kg diet groups, while it was detected in the 7 and 35 mg PN HCl/kg diet groups. There was a significant correlation between the PLP and PN levels in the small intestine and colon (r50.67, p,0.05 for small intestine; r50.54, p,0.05 for colon).
Discussion
The purpose of this study was to compare the responses of the concentrations of B 6-vitamers among several tissues to the dietary level of B6 in a single experiment. Interestingly, the elevations in the PLP level of small intestine and adipose tissue were most profound from the 0 mg PN HCl/kg diet to the 35 mg PN HCl/kg diet ( Table 2 ). The concentrations of PLP in such tissues with the 7 mg PN HCl/kg diet appeared to be lower than those in other tissues. Thus, there is an inverse association between the overall response of tissue PLP and tissue PLP level at 7 mg PN HCl/kg diet (Fig. 1) . Generally, the higher responses of PLP to dietary supplemental B6 appeared to be observed in the tissues with a low level of PLP. At present, the physiological significance of the high response of the PLP level in adipose tissue is unknown.
The colon level of PLP also showed a relatively high sensitivity among the 11 tissues examined and a broad dose-dependent response to dietary level of B6 (from 0 mg to 35 mg PN HCl/kg diets). There is increasing epidemiological evidence for the role of B6 status as a protective factor against colon cancer (4) (5) (6) , while there appears to be controversy over the role of B6 in other cancers such as breast, prostate, lung, bladder, pancreatic, ovarian, gastric and oral cancers (7-16). These facts raise the possibility that the remarkable anti-colon tumor effect of dietary B6 might be at least in part related to the higher sensitivity of PLP in the colon to dietary B6. Further study is necessary to examine the effect of dietary B6 on the status of B6 in the mammary gland, prostate, bladder and ovary, among others. Compared with the 0 mg PN HCl/kg diet, the 1 mg PN HCl/kg diet significantly elevated the level of PLP in the small intestine, liver and kidney, but not in other tissues and serum. Thus, the PLP levels in the small intestine, liver and kidney appear to be sensitive to the 1 mg PN HCl/kg diet, and the intake of this low level of B6 (1 mg PN HCl/kg diet) appears to cause preferential accumulation of PLP in such tissues.
In general, the responses of PLP in many tissues showed remarkable change between 1 mg and 7 mg PN HCl/kg diets ( Table 2 ). In addition, the 7 mg PN HCl/ kg diet appeared to reach around the saturation level because there was no significant difference in the PLP level of many tissues and serum between the 7 mg and 35 mg PN HCl/kg diets, except in adipose tissue, spleen and stomach. Thus, these results are consistent with the recommended level of 7 mg PN HCl/kg diet, as suggested previously (17) .
The 35 mg PN HCl/kg diet is considered to constitute an excessive level of dietary B6. Unexpectedly, such excessive intake of B6 (35 mg PN HCl/kg diet) significantly elevated the level of PLP in adipose tissue, spleen and stomach when compared to the recommended intake (7 mg PN HCl/kg diet), but not in other tissues. This implies that these tissues are susceptible to excessive B6 intake (35 mg PN HCl/kg diet). In addition, the 7 mg PN HCl/kg diet was insufficient for the saturation of the PLP level in such tissues, and more consumption of B6 appears to be necessary to reach the saturation levels. Thus, it is important to study the harmful effect of excessive B6 intake on these tissues.
Of interest is the finding that dietary supplementation of PN HCl caused significantly higher PN level as well as PLP in small intestine and colon, while the PN levels in serum and other tissues were unaffected. It has been reported that colonocytes can take up extracellular PN by a specific and carrier-mediated process (31) . Thus, the remarkable elevation in the PN level in the small intestine and colon by supplemental PN might be related to the marked elevation in the PLP level. Although the liver is believed to be the active organ that metabolizes the absorbed PN into PL or PLP, which can be utilized in extra-hepatic tissues (32) , we speculate that the PN absorbed from the diet can be partially metabolized to PLP within the absorptive small intestine and colon cells. Further study is necessary to test this possibility. In this study, dietary supplemental B6 significantly elevated the PL level in the lung and brain and the PM level in the small intestine. However, the implications of these findings are unknown at present.
Many studies have indicated that blood PLP is an excellent indicator that reflects the nutritional status of B6. Our study also showed a striking elevation in serum PLP of mice fed the 7 mg PN HCl/kg diet compared with the 1 mg PN HCl/kg diet, and the serum PLP reached the saturation level around the recommended level of 7 mg PN HCl/kg diet. However, there was no difference in serum PLP between the 0 mg PN HCl/kg diet and the 1 mg PN HCl/kg diet, while there was a significant difference in the PLP level in the small intestine, liver and kidney between them. Thus, serum PLP might not be a sensitive indicator in the cases of severe B6 deficiency. There was also no difference in serum PLP between the 7 mg and 35 mg PN HCl/kg diets, while there was a significant difference in the PLP level in adipose tissue, spleen and stomach between the two groups. This implies that serum PLP level does not reflect the B6 status in such tissues in cases of excessive B6 consumption. Taking these findings together, serum PLP appears to be a good indicator of B6 status in the range from the 1 mg PN HCl/kg diet to 7 mg PN HCl/kg diet.
In conclusion, our study provides evidence for the differential responses of B6 status in various tissues to the dietary level of PN. Among the tissues examined, noteworthy responses of B6-vitamers in small intestine, colon and adipose tissue were observed. In general, the overall responses of the PLP level to dietary B6 from 0 mg to 35 mg PN HCl/kg diets appear to be more remarkable in the tissues, such as small intestine, adipose tissues and colon, with lower PLP concentrations. These findings might promote understanding of the relationship between the B6-responsive diseases in several tissues and dietary B6.
